-
11.
公开(公告)号:LT1965816T
公开(公告)日:2017-07-25
申请号:LT06848618
申请日:2006-12-14
Applicant: OXTHERA INTELLECTUAL PROPERTY AB
Inventor: SIDHU HARMEET , KAUL POONAM
-
12.
公开(公告)号:DK1965816T3
公开(公告)日:2017-06-26
申请号:DK06848618
申请日:2006-12-14
Applicant: OXTHERA INTELLECTUAL PROPERTY AB
Inventor: SIDHU HARMEET , KAUL POONAM
-
公开(公告)号:SI1962873T1
公开(公告)日:2013-10-30
申请号:SI200531760
申请日:2005-12-14
Applicant: OXTHERA INTELLECTUAL PROPERTY AB
Inventor: KAUL POONAM
-
14.
公开(公告)号:AU2006326016B2
公开(公告)日:2013-10-10
申请号:AU2006326016
申请日:2006-12-14
Applicant: OXTHERA INTELLECTUAL PROPERTY AB
Inventor: SIDHU HARMEET , KAUL POONAM
Abstract: The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery of one or more oxalate-reducing pharmaceutical compositions to the intestinal tracts of persons and animals. The methods and compositions can be used in treating and preventing oxalate-related conditions. A composition of the invention comprises an oral delivery vehicle comprising an oxalate degrading bacteria, one or more cryopreserving agents and one or more excipients. A composition of the invention is enteric coated and has a suitable shelf-life and acceptable properties to avoid negative impact from gastric fluid when it is orally administered.
-
-
-